There is a real-world need for a shift in engineering philosophy towards disease-specific, outcomes-based technology. This
need is so great that we've formed strategic partnerships with organizations that are investing millions of dollars in
the research and development of diagnostic technologies that can better detect mTBI. To help with this effort, we built
Tomorrow's MR, the SIGNA™ Premier, an advanced MR system equipped with innovative coil and gradient technology that directly
links to cloud-based analytics. It's the future of MR technology and it's ready today.
Watch the video
First impressions with SIGNA Premier
First impressions with AIR Technology